Analyst ratings and price targets can significantly influence investor sentiment and stock prices. The reiterated 'Buy' rating and maintained price target of $61 by Needham analyst Mike Matson indicates a positive outlook for Boston Scientific, which could lead to an increase in its stock price in the short term.